New weekly shot aims to tame blood sugar and shed pounds in type 2 diabetes
NCT ID NCT06611930
First seen Feb 28, 2026 · Last updated May 04, 2026 · Updated 12 times
Summary
This study tested whether a weekly injection of CK-0045 could improve blood sugar after meals and reduce body weight in adults with type 2 diabetes and overweight or obesity. About 90 participants received either CK-0045 or a placebo for 16 weeks. The trial was terminated early, so results may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Reserach Services Mannheim GmbH
Mannheim, Baden-Wurttemberg, 68167, Germany
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, D-41460, Germany
Conditions
Explore the condition pages connected to this study.